Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy

British Journal of Cancer

Volumn 76, Issue 6, 1997, Pages 689-693

  Griffiths, L ^a   Stratford, I J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5 Fluorouracil; Angiogenesis; Gliostatin; Platelet derived endothelial cell growth factor; Thymidine phosphorylase

Indexed keywords

FLUOROURACIL; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PYRIMIDINE ANTAGONIST; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; CANCER INVASION; ENZYME ACTIVITY; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

EID: 0030767340     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.447     Document Type: Review

References (55)

1. Asai K, Hirano T, Kaneko S, Moriyama A, Nakanishi K, Isobe I, Eksioglu YZ and Kato T (1992a) A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma. J Neurochem 59: 307-317
2. Asai K, Nakanishi K, Isobe I, Eksioglu YZ, Hirano T, Hama K, Miyamoto T and Kato T (1992b) Neurotrophic action of gliostatin on cortical-neurons - identity of gliostatin and platelet-derived endothelial-cell growth-factor. J Biol Chem 267: 20311-20316
3. Asai K, Hirano T, Matsukawa K, Kusada J, Takechi M, Otsuka T, Matsui N and Kato T (1993) High concentrations of immunoreactive gliostatin/platelet-derived endothelial cell growth factor in synovial fluid and serum of rheumatoid arthritis. Clin Chim Acta 218: 1-4
4. Barton GJ, Ponting CP, Spraggon C, Finnis C and Sleep D (1992) Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase. Protein Sci 1: 688-696
5. Claffey KP and Robinson GS (1996) Regulation of VEGF/VPF expression in tumor cells - consequences for tumor-growth and metastasis. Cancer Met Rev 15: 165-176
6. Creamer D, Jaggar R, Allen M, Li W, Bicknell R and Barker J (1996) Vascular proliferation and expression of the angiogenic factor platelet derived endothelial cell growth factor thymidine phosphorylase (PDECGF/TP) in psoriasis. J Invest Dermatol 106: 180
7. Desgranges C, Razaka G, Raubaud M, Picard P, Dupuch F and Bricaud H (1982) The human blood platelet - a cellular model to study the degradation of thymine and its inhibition. Biochem Pharmacol 31: 2755-2759
8. Desgranges C, Baptiste N, Megati S, Wadler S and Otter (1983) Phosphorolysis of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and other 5 substituted-2′-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets. Biochem Pharmacol 32: 3583-3590
9. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K and Ishitsuka H (1993a) Cytokines induce thymidine phosphorylase expression in tumour-cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338
10. Eda H, Fujimoto K, Watanabe S, Ishikawa T, Ohiwa T, Tatsuno K, Tanaka Y and Ishitsuka H (1993b) Cytokines induce uridine phosphorylase in mouse colon 26-carcinoma cells and make the cells more susceptible to 5′-deoxy-5-fluorouridine. Jpn J Cancer Res 84: 341-347
11. Elkouni MH, Elkouni MM and Naguib FNM (1993) Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases - implications for chemotherapy with 5-fluoropyrimidines. Cancer Res 53: 3687-3693
12. Fan TPD, Jaggar R and Bicknell R (1995) Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57-66
13. Finnis C, Dodsworth N, Pollitt CE, Carr G and Sleep D (1993) Thymidine phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 212: 201-210
14. Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? - GHA Clowes memorial lecture. Cancer Res 46: 467-473
15. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6
16. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC and Harris AL (1995) Platelet-derived endothelial cell growth factor thymidine phosphorylase expression in normal tissues - an immunohistochemical study. J Pathol 176: 183-190
17. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC and Harris AL (1996) The angiogenic factor, platelet-derived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275-280
18. Fujimoto S, Wang Y, Inoue K and Ogawa M (1985) Antitumour activity of a new fluoropyrimidine derivative, 5′-deoxy-5-fluorouridine, against murine and human experimental tumours. Jpn J Cancer Res 76: 644-650
19. Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford IJ (1997) The influence of oxygen tension and pH on expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumour cells grown in vitro and in vivo. Cancer Res. 57: 570-572
20. Hagiwara K, Stenman G, Honda H, Sahlin P, Andersson A, Miyazono K, Heldin C-H, Ishikawa F and Takaku F (1991) Organisation and chromosomal location of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol 11: 2125-2132
21. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S and Yamada Y (1994) Angiogenic activity of enzymes. Nature 368: 198
22. Heldin NE, Usuki K, Bergh J, Westermark B and Heldin C-H (1993) Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines. Br J Cancer 68: 708-711
23. Iltzsch MH, Kouni MH, Cha S (1985) Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24: 6799-6807
24. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin C-H (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562
25. Leyva A, Kraal I, Lankelma J, Delemarre JFM and Pinedo HM (1983) High uridine phosphorylase activity in human melanoma tumor. Anticancer Res 3: 227-232
26. Luccioni C, Beaumatin J, Bardot V and Lefrancois D (1994) Pyrimidine nucleotide-metabolism in human colon carcinomas - comparison of normal tissues, primary tumors and xenografts. Int Jn Cancer 58: 517-522
27. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y and Sowa M (1996) Thymidine phosphorylase/platelet-derived endothelial-cell growth-factor expression associated with hepatic metastasis in gastric-carcinoma. Br J Cancer 73: 884-888
28. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y and Akiyama S (1995) Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial growth factor/thymidine phosphorylase. Cancer Res 55: 1687-1690
29. Miyazono K, Okabe T, Urabe A, Takaku F and Heldin C-H (1987) Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098-4103
30. Moghaddam A and Bicknell R (1992) Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31: 12141-12146
31. Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R (1995) Thymidine phosphorylase is angiogenic and promotes tumour growth. Proc Natl Acad Sci USA 92: 998-1002
32. Naguib FMN, Levesque DL, Wang EC, Panzica RP and El Kouni MH (1993) Barbituric-acid, potent and specific inhibitors of uridine phosphorylase. Biochem Pharmacol 46: 1273
33. O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris AL (1995) Different angiogenic pathways characterise superficial and invasive bladder cancer. Cancer Res 55: 510-513
34. Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Stratford IJ and Harris AL (1995) Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675
35. Pauly JL, Paolini, NS, Ebarb RL and Germain MJ (1978) Elevated thymidine phosphorylase activity in the plasma and ascitic fluids of tumor-bearing animals. Proc Soc Exp Biol Med 157: 262-267
36. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS and Germain MJ (1977) Identification and comparitive analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 58: 1587-1590
37. Reynolds K, Farazaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL and Bicknell R (1994) Correlation of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234-1238
38. Saeki T, Takashima S, Hosokawa S, Morikawa S, Nagasako K, Masaki T, Salomon DS and Ishitsuka H (1996) Differential expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) in nonpolypoid and polypoid lesions of the colon. Int J Oncol 8: 1105-1111
39. Sanflippo O, Camici M, Tozzi MG, Turrani M, Faranda A, Ipata PL and Silvestrini R (1994) Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma. Cancer Biochem Biophys 14: 57-66
40. Schwartz EL, Hoffmam M, O'Conner CJ and Wadler S (1992) Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cells. Biochem Biophys Res Comm 182: 1232-1239
41. Schwartz EL, Baptiste N, Wadler S and Makower D (1995) Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270: 19073-19077
42. Shapiro R and Valee BL (1989) Site-directed mutagenesis of histadine-13 and histadine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry 28: 7401-7408
43. Takahashi Y, Bucana CD, Liu WB, Yoneda J, Kitadai Y, Cleary KR and Ellis LM (1996) Platelet-derived endothelial-cell growth-factor in human colon-cancer angiogenesis - role of infiltrating cells. J Natl Cancer Inst 88: 1146-1151
44. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, Aoki D, Okimura H, Yamada Y, Akiyama S and Aikou T (1996a) The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 32a: 1227-1232
45. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T and Aikou T (1996b) Expression of thymidine phosporylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295
46. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T (1996c) Clinicopathological and prognostic significance of an angiogenic growth factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117
47. Tevaearai HT, Laurent PL, Suardet L, Eliason JF, Givel J-C and Odartchenko N (1992) Interactions of interferon-α2a with 5′ deoxy-5-fluorouridine in colorectal cancer cells in vitro. Eur J Cancer 28: 368
48. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T (1995) Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer (Pred Oncol) 64: 79-82
49. Usuki K, Norberg L, Larrson E, Miyazono K, Hellman U, Wernstedt C, Rubin K and Heldin C-H (1990) Localisation of platelet derived endothelial cell growth factor in human placenta and purification of an alternatively processed form. Cell Regn 1: 577-584
50. Usuki K, Miyazono K and Heldin C-H (1991) Covalent linkage between nucleotides and platelet-derived endothelial cell growth factor. J Biol Chem 266: 20525-20531
51. Usuki K, Sara J, Waltenberger J, Miyazono K, Pierce G, Thomason A and Heldin C-H (1992) Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Comm 184: 1311-1316
52. Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V and Weirnik PH (1989) Fluorouracil and recombinant alpha-2a-interferon - an active regimen against advanced colorectal-carcinoma. J Clin Oncol 7: 1769-1775
53. Woodman PW, Sariff AW and Heidelberger C (1980) Inhibition of nucleoside phosphorylase cleavage of 5-fluoro-2′-deoxyuridine by 2,4-pyrimidinedione derivatives. Biochem Pharmacol 29: 1059-1063
54. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K and Akiyama S (1990) Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1034: 107-113
55. Zimmerman M and Seidenberg J (1964) Deoxyribosyl transfer. J Biol Chem 239: 2618-2621